Your browser doesn't support javascript.
loading
Cellular proteolytic modification of tumor-suppressor CYLD is critical for the initiation of human T-cell acute lymphoblastic leukemia.
Arora, Mansi; Kaul, Deepak; Varma, Neelam; Marwaha, R K.
Affiliation
  • Arora M; Department of Experimental Medicine & Biotechnology, Post-Graduate Institute of Medical Education & Research, Chandigarh 160012, India.
  • Kaul D; Department of Experimental Medicine & Biotechnology, Post-Graduate Institute of Medical Education & Research, Chandigarh 160012, India. Electronic address: dkaul_24@hotmail.com.
  • Varma N; Department of Hematology, Post-graduate Institute of Medical Education & Research, Chandigarh 160012, India.
  • Marwaha RK; Department of Pediatrics, Post-graduate Institute of Medical Education & Research, Chandigarh 160012, India.
Blood Cells Mol Dis ; 54(1): 132-8, 2015 Jan.
Article in En | MEDLINE | ID: mdl-25130432

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Caspases / Tumor Suppressor Proteins / Protein Modification, Translational / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Proteolysis / Neoplasm Proteins Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Language: En Journal: Blood Cells Mol Dis Journal subject: HEMATOLOGIA Year: 2015 Document type: Article Affiliation country: India Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Caspases / Tumor Suppressor Proteins / Protein Modification, Translational / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Proteolysis / Neoplasm Proteins Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Language: En Journal: Blood Cells Mol Dis Journal subject: HEMATOLOGIA Year: 2015 Document type: Article Affiliation country: India Country of publication: Estados Unidos